糖尿病性黄斑水肿：新的有前景的治疗方法。
Diabetic macular edema: New promising therapies.
作者信息
Shamsi Hanan N Al, Masaud Jluwi S, Ghazi Nicola G
机构信息
Hanan N Al Shamsi, Jluwi S Masaud, Nicola G Ghazi, The Vitroretinal Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia.
出版信息
World J Diabetes. 2013 Dec 15;4(6):324-38. doi: 10.4239/wjd.v4.i6.324.
Abstract
The treatment of diabetic macular edema is rapidly evolving. The era of laser therapy is being quickly replaced by an era of pharmacotherapy. Several pharmacotherapies have been recently developed for the treatment of retinal vascular diseases such as diabetic macular edema. Several intravitreal injections or sustained delivery devices have undergone phase 3 testing while others are currently being evaluated. The results of clinical trials have shown the superiority of some of these agents to laser therapy. However, with the availability of several of these newer agents, it may be difficult to individualize treatment options especially those patients respond differently to various therapies. As such, more effort is still needed in order to determine the best treatment regimen for a given patient. In this article, we briefly summarize the major new therapeutic additions for the treatment of diabetic macular edema and allude to some future promising therapies.
摘要
糖尿病性黄斑水肿的治疗正在迅速发展。激光治疗时代正迅速被药物治疗时代所取代。最近已开发出几种用于治疗视网膜血管疾病（如糖尿病性黄斑水肿）的药物疗法。几种玻璃体内注射剂或缓释装置已进入3期试验，而其他一些正在评估中。临床试验结果表明，其中一些药物优于激光治疗。然而，随着这些新型药物的出现，可能难以实现个体化治疗方案，尤其是那些对各种疗法反应不同的患者。因此，仍需要付出更多努力来确定针对特定患者的最佳治疗方案。在本文中，我们简要总结了治疗糖尿病性黄斑水肿的主要新增治疗方法，并提及一些未来有前景的疗法。
相似文献
1
Diabetic macular edema: New promising therapies.糖尿病性黄斑水肿：新的有前景的治疗方法。
World J Diabetes. 2013 Dec 15;4(6):324-38. doi: 10.4239/wjd.v4.i6.324.
2
Diabetic macular edema: new trends in management.糖尿病性黄斑水肿：管理的新趋势。
Expert Rev Clin Pharmacol. 2012 Jan;5(1):55-68. doi: 10.1586/ecp.11.67.
3
The Evolving Treatment of Diabetic Retinopathy.糖尿病视网膜病变的治疗进展
Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020.
4
Diabetic macular edema: changing treatment paradigms.糖尿病性黄斑水肿：不断变化的治疗模式
Curr Opin Ophthalmol. 2014 Nov;25(6):502-7. doi: 10.1097/ICU.0000000000000102.
5
Current and Future Pharmacologic Therapies for Diabetic Retinopathy.当前和未来用于糖尿病视网膜病变的药物治疗。
Curr Pharm Des. 2018;24(41):4903-4910. doi: 10.2174/1381612825666190130140717.
6
Laser-based strategies to treat diabetic macular edema: history and new promising therapies.基于激光的糖尿病性黄斑水肿治疗策略：历史与新的有前景的疗法。
J Ophthalmol. 2014;2014:769213. doi: 10.1155/2014/769213. Epub 2014 Sep 22.
7
Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.玻璃体切除术联合玻璃体内注射曲安奈德及黄斑区激光光凝治疗非牵拉性糖尿病性黄斑水肿
Korean J Ophthalmol. 2013 Jun;27(3):186-93. doi: 10.3341/kjo.2013.27.3.186. Epub 2013 Apr 25.
8
Update on treatments for diabetic macular edema.糖尿病性黄斑水肿治疗的最新进展。
Curr Opin Ophthalmol. 2008 May;19(3):185-9. doi: 10.1097/ICU.0b013e3282fb7c45.
9
Vascular endothelial growth factor and diabetic macular edema.血管内皮生长因子与糖尿病性黄斑水肿
Surv Ophthalmol. 2016 Nov-Dec;61(6):759-768. doi: 10.1016/j.survophthal.2016.03.010. Epub 2016 Apr 1.
10
Intravitreal triamcinolone for refractory diabetic macular edema.玻璃体内注射曲安奈德治疗难治性糖尿病性黄斑水肿。
Ophthalmology. 2002 May;109(5):920-7. doi: 10.1016/s0161-6420(02)00975-2.
引用本文的文献
1
Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.马来酸噻吗洛尔滴眼液，一种β阻断剂眼药水，可改善视网膜静脉阻塞模型中的水肿。
Mol Vis. 2023 Oct 15;29:188-196. eCollection 2023.
2
Long-term hemodialysis improved and stabilized diabetic macular edema: two case reports.长期血液透析改善并稳定了糖尿病性黄斑水肿：两例病例报告。
Int J Ophthalmol. 2021 Mar 18;14(3):472-475. doi: 10.18240/ijo.2021.03.23. eCollection 2021.
3
Unfolded Protein Response Pathways Correlatively Modulate Endoplasmic Reticulum Stress Responses in Rat Retinal Müller Cells.未折叠蛋白反应途径相关调节大鼠视网膜穆勒细胞内质网应激反应
J Ophthalmol. 2019 Feb 24;2019:9028483. doi: 10.1155/2019/9028483. eCollection 2019.
4
Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema.地塞米松玻璃体内植入物治疗糖尿病性黄斑水肿患者的疗效
Eur Endocrinol. 2014 Aug;10(2):111-116. doi: 10.17925/EE.2014.10.02.111. Epub 2014 Aug 28.
5
Six-month postoperative outcomes of intraoperative OCT-guided surgical cystotomy for refractory cystoid macular edema in diabetic eyes.糖尿病性眼病中难治性黄斑囊样水肿患者术中光学相干断层扫描（OCT）引导下手术性膀胱切开术的术后6个月结局
Clin Ophthalmol. 2017 Nov 23;11:2099-2105. doi: 10.2147/OPTH.S150385. eCollection 2017.
6
Clinical observation of the efficacy of Bevacizumab combined with argon green laser in treating fundus macular edema.贝伐单抗联合氩绿激光治疗眼底黄斑水肿的疗效临床观察
Exp Ther Med. 2017 Apr;13(4):1480-1484. doi: 10.3892/etm.2017.4145. Epub 2017 Feb 21.
7
Diabetic Retinopathy and Diabetic Macular Edema.糖尿病视网膜病变和糖尿病性黄斑水肿。
Dev Ophthalmol. 2016;55:137-46. doi: 10.1159/000438970. Epub 2015 Oct 26.
8
Planned foveal detachment technique for the resolution of diffuse diabetic macular edema.用于解决弥漫性糖尿病性黄斑水肿的计划性黄斑中心凹脱离技术
Jpn J Ophthalmol. 2015 Sep;59(5):279-87. doi: 10.1007/s10384-015-0390-4. Epub 2015 Jul 30.
9
Recent progress in the genetics of diabetic microvascular complications.糖尿病微血管并发症遗传学研究进展。
World J Diabetes. 2015 Jun 10;6(5):715-25. doi: 10.4239/wjd.v6.i5.715.
10
Advances in diabetic retinopathy.糖尿病视网膜病变的进展
Indian J Endocrinol Metab. 2014 Nov;18(6):772-7. doi: 10.4103/2230-8210.140225.
本文引用的文献
1
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.《da Vinci 研究：VEGF 陷阱眼内注射治疗糖尿病黄斑水肿的一年结果》。
Ophthalmology. 2012 Aug;119(8):1658-65. doi: 10.1016/j.ophtha.2012.02.010. Epub 2012 Apr 24.
2
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.一项为期2年的玻璃体腔内注射贝伐单抗或激光治疗（BOLT）糖尿病性黄斑水肿的前瞻性随机对照试验：24个月数据：报告3
Arch Ophthalmol. 2012 Aug;130(8):972-9. doi: 10.1001/archophthalmol.2012.393.
3
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.雷珠单抗治疗糖尿病性黄斑水肿：两项 III 期随机临床试验（RISE 和 RIDE）的结果。
Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11.
4
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.氟轻松玻璃体内植入治疗糖尿病性黄斑水肿：一项 3 年多中心、随机、对照临床试验。
Ophthalmology. 2011 Aug;118(8):1580-7. doi: 10.1016/j.ophtha.2011.02.048.
5
Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography.阈下微脉冲二极管激光和倍频钕：钇铝石榴石激光治疗糖尿病性黄斑水肿：一项使用多焦视网膜电图的前瞻性随机研究。
Photomed Laser Surg. 2011 Nov;29(11):727-33. doi: 10.1089/pho.2010.2830. Epub 2011 May 25.
6
Subconjunctival sirolimus in the treatment of diabetic macular edema.经结膜下注射西罗莫司治疗糖尿病性黄斑水肿。
Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1627-33. doi: 10.1007/s00417-011-1694-9. Epub 2011 May 13.
7
A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.一项为期 2 年的多中心、随机、双盲、2 期试验，评估聚乙二醇化人血管内皮生长因子抑制剂（贝伐单抗）治疗糖尿病性黄斑水肿的疗效。
Ophthalmology. 2011 Jun;118(6):1107-18. doi: 10.1016/j.ophtha.2011.02.045. Epub 2011 May 6.
8
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.地塞米松玻璃体内植入物治疗玻璃体切割术后糖尿病性黄斑水肿。
Retina. 2011 May;31(5):915-23. doi: 10.1097/IAE.0b013e318206d18c.
9
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.氟轻松玻璃体内植入剂长效缓释治疗糖尿病性黄斑水肿的长期疗效。
Ophthalmology. 2011 Apr;118(4):626-635.e2. doi: 10.1016/j.ophtha.2010.12.028.
10
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.RESTORE 研究：雷珠单抗单药治疗或联合激光治疗与单纯激光治疗糖尿病黄斑水肿的比较。
Ophthalmology. 2011 Apr;118(4):615-25. doi: 10.1016/j.ophtha.2011.01.031.
Zotero 插件